Cancer stem cells (CSCs) represent a distinct subpopulation within tumours, characterised by their capacity for self‐renewal and differentiation. These cells are pivotal in driving tumour growth, ...

Baylor University researchers have developed a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells. Michael S.

AHNAK, a colossal scaffolding protein of approximately 700 kDa, has emerged as a critical player in various cellular functions, most notably in the regulation of cell architecture, signalling and ...

Tumor biology is increasingly recognized as a field shaped by the intricate interplay between malignant cells and their surrounding microenvironment. Recent ...

Cancer biology increasingly recognizes that cancer stem cells (CSCs) represent a critical subpopulation within tumors, marked by their self-renewal, ...

Scientists have discovered that a rare “mirror-image” version of the amino acid cysteine can dramatically slow the growth of ...

Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...

A lack of vitamin B2 makes tumour cells more susceptible to a unique form of cell death. This was discovered by researchers at the Rudolf Virchow Centre at the University of Würzburg.

A new study led by researchers at Adelaide University and published in Science Advances reveals why some cancers can grow and survive in the body, while others cannot. It turns out that intense ...

HeLa cells are the most famous human cells in science. Discover how cervical cancer, HPV proteins, and bioethics shaped one ...

Cancer cells undergo physically constraining processes, such as intravasation, extravasation, and tissue infiltration, that lead to acute mechanical stress. How mechanical confinement rewires the ...

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.